Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Orix ADR | IX | May 2, 2024 | 103.61 | +2.33 |
Orla Mining | ORLA | May 2, 2024 | 3.92 | -1.01 |
Ormat Technologies | ORA | May 2, 2024 | 66.71 | +1.48 |
Orrstown Financial Services | ORRF | May 2, 2024 | 26.34 | +0.08 |
Orthofix Medical | OFIX | May 2, 2024 | 13.24 | +1.65 |
OrthoPediatrics | KIDS | May 2, 2024 | 31.81 | +2.48 |
Oscar Health A | OSCR | May 2, 2024 | 18.09 | +4.21 |
Oshkosh | OSK | May 2, 2024 | 113.36 | +0.52 |
OSI Systems | OSIS | May 2, 2024 | 135.74 | +3.56 |
Osiris Acquisition A | OSI | May 2, 2024 | 10.71 | 0.00 |
Osisko Development | ODV | May 2, 2024 | 1.93 | -3.98 |
Osisko Gold Royalties | OR | May 2, 2024 | 15.60 | +0.71 |
Ostin Technology Group | OST | May 2, 2024 | 0.43 | -0.05 |
Otis Worldwide | OTIS | May 2, 2024 | 91.77 | +0.37 |
Otter Tail | OTTR | May 2, 2024 | 87.05 | +0.39 |
Ouster | OUST | May 2, 2024 | 9.61 | +3.33 |
Outfront Media | OUT | May 2, 2024 | 16.04 | -1.53 |
Outlook Therapeutics | OTLK | May 2, 2024 | 8.50 | 0.00 |
Outset Medical | OM | May 2, 2024 | 3.00 | +5.26 |
Overseas Shipholding A | OSG | May 2, 2024 | 6.38 | +3.91 |
Ovid Therapeutics | OVID | May 2, 2024 | 3.07 | +0.33 |
Ovintiv | OVV | May 2, 2024 | 51.07 | +0.67 |
Owens & Minor | OMI | May 2, 2024 | 24.51 | +2.08 |
Owens Corning | OC | May 2, 2024 | 173.14 | +3.01 |
Owlet A | OWLT | May 2, 2024 | 4.25 | -2.97 |
Oxbridge Re | OXBR | May 2, 2024 | 1.17 | +6.51 |
Oxford Industries | OXM | May 2, 2024 | 108.84 | +1.14 |
Oxford Lane Capital | OXLC | May 2, 2024 | 5.10 | +0.59 |
Oxford Lane Capital 2024 Pref | OXLCM | May 2, 2024 | 25.00 | +0.10 |
Oxford Lane Capital 2027 Pref | OXLCP | May 2, 2024 | 23.52 | -0.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.